| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED TRANSFER OF 100% EQUITY INTEREST IN AN UPSTREAM SHAREHOLDER | 1 | SGX Company Announcements | ||
| 15.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::ANNOUNCEMENT OF APPOINTMENT | 1 | SGX Company Announcements | ||
| 15.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::ANNOUNCEMENT OF CESSATION | 1 | SGX Company Announcements | ||
| 15.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 5 | SGX Company Announcements | ||
| 11.05. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 30.04. | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Increase In Q1 Income | 3 | RTTNews | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 30.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 2 | SGX Company Announcements | ||
| 30.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 30.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 2 | SGX Company Announcements | ||
| 29.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE EVALUATION REPORT ON THE 2025 ACTION PLAN AND THE ADOPTION OF THE 2026 ACTION PLAN | - | SGX Company Announcements | ||
| 29.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 4TH BOARD MEETING FOR FY2026 | - | SGX Company Announcements | ||
| 29.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FIRST QUARTER RESULTS | - | SGX Company Announcements | ||
| 16.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 16.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 3RD BOARD MEETING FOR FY2026 | 2 | SGX Company Announcements | ||
| 02.04. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::INTERESTED PERSON TRANSACTION::THE PROPOSED PROVISION OF A GUARANTEE FOR AN INTERESTED PERSON TRANSACTION | - | SGX Company Announcements | ||
| 31.03. | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Full Year Income Retreats | 2 | RTTNews | ||
| 30.03. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 30.03. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: INTERESTED PERSON TRANSACTION::THE PROPOSED PROVISION OF A GUARANTEE FOR AN INTERESTED PERSON TRANSACTION | 1 | SGX Company Announcements | ||
| 30.03. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: INTERESTED PERSON TRANSACTION::THE PROPOSED ENTRY INTO THE FINANCIAL SERVICES AGREEMENT BETWEEN THE COMPANY AND TPGF AS AN IPT | 2 | SGX Company Announcements | ||
| 30.03. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::SHAREHOLDERS RETURN PLAN FOR 2026 TO 2028 | 1 | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 161,35 | +0,06 % | Astrazeneca bekommt US-Zulassung für Blutdrucksenker Baxdrostat | DJ Astrazeneca bekommt US-Zulassung für Blutdrucksenker Baxdrostat
Von Adria Calatayud
DOW JONES--Astrazeneca hat die US-Zulassung für einen neuartigen Bluthochdrucksenker erhalten. Das bisher... ► Artikel lesen | |
| TEVA | 29,400 | 0,00 % | Teva: European Medicines Agency Accepts Marketing Authorization Application For TEV-'749 | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals International GmbH, a unit of Teva Pharmaceutical Industries (TEVA), and Medincell announced that the European Medicines Agency has accepted the... ► Artikel lesen | |
| SINOPHARM | 1,920 | -1,41 % | Sinopharm expands its international presence | ||
| CSPC PHARMA | 0,836 | -1,41 % | CSPC PHARMA Ustekinumab Injection Approved for Market Launch | ||
| WUXI BIOLOGICS | 3,570 | +0,85 % | WUXI BIO (02269): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 10, 2026 | ||
| OPKO HEALTH | 1,070 | -2,73 % | OPKO Health, Inc.: OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results | MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,892 | 0,00 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY | ||
| GEDEON RICHTER | 34,040 | +0,71 % | Gedeon Richter Plc.: Strategic Partnerships in Focus: Gedeon Richter at Chessparty Stockholm | BUDAPEST, Hungary, May 5, 2026 /PRNewswire/ -- Gedeon Richter was proud to be represented at Chessparty, the renowned chess festival held on April 17th-18th at Stockholm's Avicii Arena, marking... ► Artikel lesen | |
| DR REDDYS | 11,600 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| BAYER | 38,510 | -1,03 % | BARCLAYS stuft BAYER AG auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Bayer von 48 auf 50 Euro angehoben und die Einstufung auf "Overweight" belassen. Bayer habe mit der Gewinnentwicklung... ► Artikel lesen | |
| MERCK KGAA | 128,60 | +1,74 % | BARCLAYS stuft MERCK KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Merck KGaA mit einem Kursziel von 130 Euro auf "Equal Weight" belassen. Das erste Quartal des Pharma- und Chemiekonzerns... ► Artikel lesen | |
| AKARI THERAPEUTICS | 18,230 | -0,22 % | Akari Therapeutics Plc: Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models | An ADC with a novel RNA spliceosome modulating payload PH1 paired with a KRAS inhibitor demonstrates synergistic cytotoxic activity against KRAS G12D and G12C- driven pancreatic cancer modelsData... ► Artikel lesen | |
| NOVO NORDISK | 38,660 | +1,63 % | BARCLAYS stuft NOVO NORDISK auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Novo Nordisk mit einem Kursziel von 300 dänischen Kronen auf "Equal Weight" belassen. Nach starkem Start hätten... ► Artikel lesen | |
| ELI LILLY | 919,70 | +0,10 % | Novo Nordisk hält Boden gegen Lilly-Konkurrenz | Novo Nordisk steht bei zwei Analystenteams im Fokus. Die Verschreibungsdaten für Wegovy und die Langzeitstudie CagriSema sind die bestimmenden Themen, die Einstufungen bleiben neutral. Barclays behält... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 32,560 | -0,09 % | Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO (miltefosine) | IMPAVIDO is the first and only FDA-approved oral therapy for visceral, cutaneous, and mucosal leishmaniasis caused by specific Leishmania speciesLeishmaniasis is a rare but potentially life-threatening... ► Artikel lesen |